Regulation And Legal
Orchid Pharma Fined ₹2,000 by Exchanges for Delay
Orchid Pharma's Board noted fines of ₹2,000 each from NSE and BSE for a one-day delay in filing its FY 2025-26 Annual Report.
The fines, totaling ₹2,360 each including GST, were paid, and management w